Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EBIT Growth

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   EBIT Growth(%) 29.026.6673.35-0.161.95

What is the latest EBIT Growth ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EBIT Growth ratio of SYNCOM FORMULATIONS (INDIA) is 29.02 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202429.02
Mar20236.66
Mar202273.35
Mar2017-0.16
Mar20161.95

How is EBIT Growth of SYNCOM FORMULATIONS (INDIA) Trending?

Years EBIT Growth % Change
Mar2024 29.02
335.74
Mar2023 6.66
-90.92
Mar2022 73.35
Positive
Mar2017 -0.16
Negative
Mar2016 1.95 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EBIT Growth ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,951.4 Cr -4.8% 34.2% 76.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,076.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹173,924.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,456.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,197.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,761.0 Cr 0.8% -0.9% 17.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-4.8%

34.2%

76.8%

SENSEX

0.9%

1.8%

11.1%


You may also like the below Video Courses